Most Recent
‘Considerable disquiet’: Pelvic mesh group members can challenge $405M settlements
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.
In latest class action loss, Bayer defeats case over Essure device
Medical device maker Bayer has successfully defended a class action over its Essure contraceptive, with a judge finding the evidence fell short of proving the device caused chronic inflammation.
Allergan hit with class action over breast implants linked to cancer
US drug company Allergan is facing a class action on behalf of women implanted with textured breast implants that were recalled after they were linked to a form of non-Hodgkin lymphoma. 
Group members get nothing in RoundUp class action settlement
A judge has approved a settlement in a class action against Monsanto under which group members will get nothing, after he rejected claims that the company's Roundup weed killer is carcinogenic.
Parties race to settle Exactech joint implant class action
The law firm running a class action against Exactech over allegedly faulty joint implants is facing the "impossible task" of settling the case by January, the "drop dead" deadline for resolving the claim under its US parent company's restructuring.
$405M pelvic mesh settlement distribution can’t ‘drag on’, judge says
A judge has expressed concerns after hearing that up to 20,000 group members in three pelvic mesh class actions have yet to receive payment from $405 million in settlements approved in March last year.
Class action accuses Exactech of supplying faulty joint implants
A Sydney law firm has filed a class action accusing private equity-owned medical device maker Exactech of supplying faulty joint implants that were subject to deterioration due to a packaging defect, caused serious medical complications in patients. 
‘Suboptimal’: Judge takes Monsanto to task for its approach in Roundup class action
Deciding an “unusually difficult” costs application, a judge has declined to award Monsanto all of its costs for defending a class action alleging its Roundup weed killer is carcinogenic, saying the agrochemical giant should have pushed harder for a split trial. 
AstraZeneca, Merck face potential class action over heartburn drugs
A law firm is investigating claims against the manufacturers of popular heartburn and acid reflux drugs, alleging they could be responsible for causing stomach cancers and kidney failure in approximately 100,000 people.
Monsanto defeats class action alleging weed killer Roundup causes cancer
A judge has dismissed a class action alleging Monsanto's Roundup weed killer is carcinogenic but did not go so far as to say it definitively does not cause cancer, while also dressing down the lawyers for both sides for causing delays in the case.